How Inovio Pharmaceuticals Could Make It To ‘The Show’

Source: Improvement of DNA vaccinations by Adjuvants and sophisticated delivery devices. Article by David M Eberhart.

Summary

It takes a multitude of disciplines for a pharmaceutical company to successfully bring a FDA approved vaccine to market.

Inovio recently announced the completion of another successfully funded vaccine PI/PIIa trial for SARS-CoV, which has a similar blueprint to SARS-CoV-2.

Synthetic DNA plasmids are delivered via electroporation. […]

The recent out break of SARS-CoV-2, also known as COVID19, has created opportunities for investors to place their bets on who they believe will be granted FDA approval for a vaccine to combat the Corona virus. In addition to the FDA, approval from foreign regulatory bodies are also in play and investors should understand that pharmaceutical research labs around the globe are also racing to develop their own vaccines. […]

Click here to view original web page at seekingalpha.com